Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzo Biochem Inc (NYSE:ENZ)

10.45
Delayed Data
As of Sep 22
 -0.01 / -0.10%
Today’s Change
4.88
Today|||52-Week Range
12.04
+50.58%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$483.8M

Company Description

Enzo Biochem, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines target the following conditions: inflammatory bowel disease, uveitis, human immunodeficiency virus, diabetes, and bone disorders. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.

Contact Information

Enzo Biochem, Inc.
527 Madison Avenue
New York New York 10022
P:(212) 583-0100
Investor Relations:

Employees

Shareholders

Other institutional39.17%
Mutual fund holders26.64%
Individual stakeholders12.52%

Top Executives

Elazar RabbaniChairman, Chief Executive Officer & Secretary
Barry W. WeinerPresident, CFO, Treasurer & Director
James M. O'BrienSenior Vice President-Finance
Kara CannonHead-Global Sales & Marketing
Paul C. O'BrienVice President-Global Human Resources